Results for bristol-myers squibb: 21

Bristol-Myers Squibb has announced the completion of the $2.4bn acquisition of Medarex, a leader in immune disease and cancer treatments. As a result of the transaction Medarex has now become a wholly...

NEW YORK, March 4 - Bristol-Myers Squibb on Wednesday announced a collaboration with Nissan Chemical Industries Ltd and Teijin Pharma Ltd for the development and commercialization of a drug to help maintain normal sinus rhythm...

TOKYO, Sept 16 - Japan's Taisho Pharmaceutical said on Wednesday it will pay $310 million for a 98 percent stake in Bristol-Myers Squibb Indonesia and the firm's brand assets, seeking to expand its business in...

WASHINGTON, July 31 - AstraZeneca PLC and Bristol-Myers Squibb Co won U.S. approval on Friday to sell a new diabetes drug called Onglyza. The Food and Drug Administration said it was requiring a post-approval study...

* Talks never went beyond early stage - source * Leak came after second suitor emerged - source (Adds quotes, Elan background, byline) NEW YORK, June 2 - Irish drugmaker Elan Corp and Bristol-Myers Squibb...

NEW YORK, June 2 - Irish drugmaker Elan Corp and Bristol-Myers Squibb Corp held strategic discussions last month, but they broke down in the early stages, a source familiar with the matter said on Tuesday....

LOS ANGELES, May 14 - Bristol-Myers Squibb Co <BMY.N> said on Thursday that interim results from two mid-stage studies of its leukemia drug Sprycel show that it could have potential as a treatment for a...

LONDON, Sept 16 - Bristol-Myers Squibb could walk away from its bid for biotech company ImClone Systems in certain circumstances, the U.S. drugmaker's chief financial officer said on Tuesday. Jean-Marc Huet told a Merrill Lynch...

* Prilosec cuts Plavix effectiveness by nearly half * FDA: Plavix label will highlight interaction risk (Adds details, background) WASHINGTON, Nov 17 - Common heartburn pills like Prilosec interfere with Sanofi-Aventis SA's and Bristol-Myers Squibb...

NEW YORK, Nov 15 - Bristol-Myers Squibb Co <BMY.N> said on Sunday it plans to split off its 83 percent stake in Mead Johnson Nutrition Company <MJN.N> in a deal that lets Bristol shareholders exchange...